421 related articles for article (PubMed ID: 33932413)
1. Encapsulation and pH-responsive release of bortezomib by dopamine grafted hyaluronate nanogels.
Liu L; Luan S; Zhang C; Wang R; Zhang Y; Zhang M; Sheng Q; Han G; Wang T; Song S
Int J Biol Macromol; 2021 Jul; 183():369-378. PubMed ID: 33932413
[TBL] [Abstract][Full Text] [Related]
2. Use of pH-Active Catechol-Bearing Polymeric Nanogels with Glutathione-Responsive Dissociation to Codeliver Bortezomib and Doxorubicin for the Synergistic Therapy of Cancer.
Qiu Y; Bai J; Feng Y; Shi X; Zhao X
ACS Appl Mater Interfaces; 2021 Aug; 13(31):36926-36937. PubMed ID: 34319074
[TBL] [Abstract][Full Text] [Related]
3. pH responsive biodegradable nanogels for sustained release of bleomycin.
Sahu P; Kashaw SK; Kushwah V; Sau S; Jain S; Iyer AK
Bioorg Med Chem; 2017 Sep; 25(17):4595-4613. PubMed ID: 28734664
[TBL] [Abstract][Full Text] [Related]
4. Controlled release of cisplatin from pH-thermal dual responsive nanogels.
Peng J; Qi T; Liao J; Chu B; Yang Q; Li W; Qu Y; Luo F; Qian Z
Biomaterials; 2013 Nov; 34(34):8726-40. PubMed ID: 23948167
[TBL] [Abstract][Full Text] [Related]
5. Multiresponsive Nanogels for Targeted Anticancer Drug Delivery.
Zhang Q; Colazo J; Berg D; Mugo SM; Serpe MJ
Mol Pharm; 2017 Aug; 14(8):2624-2628. PubMed ID: 28686454
[TBL] [Abstract][Full Text] [Related]
6. Comparison of nanogel drug carriers and their formulations with nucleoside 5'-triphosphates.
Vinogradov SV; Kohli E; Zeman AD
Pharm Res; 2006 May; 23(5):920-30. PubMed ID: 16715382
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronic acid-based nanogel-drug conjugates with enhanced anticancer activity designed for the targeting of CD44-positive and drug-resistant tumors.
Wei X; Senanayake TH; Warren G; Vinogradov SV
Bioconjug Chem; 2013 Apr; 24(4):658-68. PubMed ID: 23547842
[TBL] [Abstract][Full Text] [Related]
8. pH-Responsive Fluorescence Enhanced Nanogel for Targeted Delivery of AUR and CDDP Against Breast Cancer.
Cao Z; Li W; Liu R; Li C; Song Y; Liu G; Chen Y; Lu C; Lu A; Liu Y
Int J Nanomedicine; 2020; 15():8369-8382. PubMed ID: 33149581
[TBL] [Abstract][Full Text] [Related]
9. A new multiresponsive drug delivery system using smart nanogels.
Demirel GB; von Klitzing R
Chemphyschem; 2013 Aug; 14(12):2833-40. PubMed ID: 23794381
[TBL] [Abstract][Full Text] [Related]
10. pH and Reduction Dual-Responsive Nanogels as Smart Nanocarriers to Resist Doxorubicin Aggregation.
Maruf A; Milewska M; Lalik A; Wandzik I
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144713
[TBL] [Abstract][Full Text] [Related]
11. TPGS-grafted and acid-responsive soy protein nanogels for efficient intracellular drug release, accumulation, penetration in 3D tumor spheroids of drug-resistant cancer cells.
Cheng X; Zeng X; Li D; Wang X; Sun M; He L; Tang R
Mater Sci Eng C Mater Biol Appl; 2019 Sep; 102():863-875. PubMed ID: 31147058
[TBL] [Abstract][Full Text] [Related]
12. Bio-derived poly(gamma-glutamic acid) nanogels as controlled anticancer drug delivery carriers.
Bae HH; Cho MY; Hong JH; Poo H; Sung MH; Lim YT
J Microbiol Biotechnol; 2012 Dec; 22(12):1782-9. PubMed ID: 23221543
[TBL] [Abstract][Full Text] [Related]
13. Nanogel delivery systems for cationic peptides: More than a 'One Size Fits All' solution.
Kłodzińska SN; Wang Q; Molchanova N; Mahmoudi N; Vallooran JJ; Hansen PR; Jenssen H; Mørck Nielsen H
J Colloid Interface Sci; 2024 Jun; 663():449-457. PubMed ID: 38417296
[TBL] [Abstract][Full Text] [Related]
14. Dual stimuli-responsive polymeric hollow nanogels designed as carriers for intracellular triggered drug release.
Chiang WH; Ho VT; Huang WC; Huang YF; Chern CS; Chiu HC
Langmuir; 2012 Oct; 28(42):15056-64. PubMed ID: 23036055
[TBL] [Abstract][Full Text] [Related]
15. Dopamine-modified poly(ε-caprolactone) micelles for pH controlled delivery of bortezomib.
Liu L; Wang S; Qi P; Song S; Yang Y; Shi J; Han G
Int J Pharm; 2020 Nov; 590():119885. PubMed ID: 32949619
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid shell and disulfide-crosslinked core micelles for in vivo targeted delivery of bortezomib for the treatment of multiple myeloma.
Gu Z; Wang X; Cheng R; Cheng L; Zhong Z
Acta Biomater; 2018 Oct; 80():288-295. PubMed ID: 30240956
[TBL] [Abstract][Full Text] [Related]
17. Dual thermoresponsive and pH-responsive self-assembled micellar nanogel for anticancer drug delivery.
Chen D; Yu H; Sun K; Liu W; Wang H
Drug Deliv; 2014 Jun; 21(4):258-64. PubMed ID: 24102086
[TBL] [Abstract][Full Text] [Related]
18. Cell-targeted, dual reduction- and pH-responsive saccharide/lipoic acid-modified poly(L-lysine) and poly(acrylic acid) polyionic complex nanogels for drug delivery.
How SC; Chen YF; Hsieh PL; Wang SS; Jan JS
Colloids Surf B Biointerfaces; 2017 May; 153():244-252. PubMed ID: 28267669
[TBL] [Abstract][Full Text] [Related]
19. pH Responsive 5-Fluorouracil Loaded Biocompatible Nanogels For Topical Chemotherapy of Aggressive Melanoma.
Sahu P; Kashaw SK; Sau S; Kushwah V; Jain S; Agrawal RK; Iyer AK
Colloids Surf B Biointerfaces; 2019 Feb; 174():232-245. PubMed ID: 30465998
[TBL] [Abstract][Full Text] [Related]
20. An implantable smart magnetic nanofiber device for endoscopic hyperthermia treatment and tumor-triggered controlled drug release.
Sasikala ARK; Unnithan AR; Yun YH; Park CH; Kim CS
Acta Biomater; 2016 Feb; 31():122-133. PubMed ID: 26687978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
